학술논문
전자자료 공정이용 안내
우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.
공정이용 지침
- 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
- 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
- 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
- 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
- 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
- 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
- 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
- 상업적·영리적 목적으로 자료를 전송·복제·활용
- ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
- EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
- 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
- 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
- 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문'
에서 검색결과 551건 | 목록
1~20
Academic Journal
Chiu PK; Department of Surgery, SH Ho Urology Centre, The Chinese University of Hong Kong, Hong Kong, China.; Liu AQ; Department of Surgery, SH Ho Urology Centre, The Chinese University of Hong Kong, Hong Kong, China.; Lau SY; Department of Surgery, SH Ho Urology Centre, The Chinese University of Hong Kong, Hong Kong, China.; Teoh JY; Department of Surgery, SH Ho Urology Centre, The Chinese University of Hong Kong, Hong Kong, China.; Ho CC; Department of Pathology, Pamela Youde Nethersole Eastern Hospital, Hong Kong, China.; Yee CH; Department of Surgery, SH Ho Urology Centre, The Chinese University of Hong Kong, Hong Kong, China.; Hou SM; Department of Surgery, SH Ho Urology Centre, The Chinese University of Hong Kong, Hong Kong, China.; Chan CK; Department of Surgery, SH Ho Urology Centre, The Chinese University of Hong Kong, Hong Kong, China.; Tang WL; Department of Pathology, Pamela Youde Nethersole Eastern Hospital, Hong Kong, China.; Bangma CH; Department of Urology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.; Chu PS; Division of Urology, Department of Surgery, Tuen Mun Hospital, Hong Kong, China.; Poon WT; Department of Pathology, Pamela Youde Nethersole Eastern Hospital, Hong Kong, China.; Ng CF; Department of Surgery, SH Ho Urology Centre, The Chinese University of Hong Kong, Hong Kong, China.; Roobol MJ; Department of Urology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.
Publisher: Blackwell Science Country of Publication: England NLM ID: 100886721 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1464-410X (Electronic) Linking ISSN: 14644096 NLM ISO Abbreviation: BJU Int Subsets: MEDLINE
Academic Journal
Bancroft EK; Oncogenetics Team, Genetics and Epidemiology, The Institute of Cancer Research, London, UK; Cancer Genetics Unit and Academic Urology Unit, The Royal Marsden NHS Foundation Trust, London, UK.; Page EC; Oncogenetics Team, Genetics and Epidemiology, The Institute of Cancer Research, London, UK.; McHugh J; Oncogenetics Team, Genetics and Epidemiology, The Institute of Cancer Research, London, UK.; Thomas S; Cancer Genetics Unit and Academic Urology Unit, The Royal Marsden NHS Foundation Trust, London, UK.; Taylor N; Cancer Genetics Unit and Academic Urology Unit, The Royal Marsden NHS Foundation Trust, London, UK.; Pope J; Oncogenetics Team, Genetics and Epidemiology, The Institute of Cancer Research, London, UK.; Evans DG; Department of Genomic Medicine, Division of Evolution, Infection and Genomic Sciences, University of Manchester, Manchester, UK.; Rothwell J; Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK.; Grindedal EM; Department of Medical Genetics, Oslo University Hospital, Oslo, Norway.; Maehle L; Department of Medical Genetics, Oslo University Hospital, Oslo, Norway.; James P; Parkville Familial Cancer Centre, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Australia; The Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia; Department of Genetic Medicine, Royal Melbourne Hospital, Parkville, Australia.; McKinley J; Parkville Familial Cancer Centre, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Australia.; Mascarenhas L; Parkville Familial Cancer Centre, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Australia.; Side L; Wessex Clinical Genetics Service, Princess Anne Hospital, Southampton, UK.; Thomas T; Wessex Clinical Genetics Service, Princess Anne Hospital, Southampton, UK.; van Leerdam ME; Dutch Foundation for Detection of Hereditary Tumors, Leiden, The Netherlands; Department of Gastroenterology and Hepatology, Leiden University Medical Center, Leiden, The Netherlands.; van Asperen CJ; Department of Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands.; Kiemeney LALM; Radboud University Medical Center, Nijmegen, The Netherlands.; Ringelberg J; Dutch Foundation for Detection of Hereditary Tumors, Leiden, The Netherlands.; Vlaming M; Department of Genetics, Division Laboratories, Pharmacy and Biomedical Genetics, University Medical Centre Utrecht, Utrecht, The Netherlands.; Rønlund K; Department of Clinical Genetics, Vejle Hospital, University Hospital of Southern Denmark, Vejle, Denmark.; Osther PJS; Department of Urology, Vejle Hospital, University Hospital of Southern Denmark, Vejle, Denmark.; Helfand BT; John and Carol Walter Center for Urological Health, Division of Urology, Endeavor Health NorthShore University HealthSystem, Evanston, IL, USA.; Hutten CG; Internal Medicine Epidemiology, Rush Institute for Healthy Aging, Rush University Medical Center, Chicago, IL, USA.; Oldenburg RA; Department of Clinical Genetics, Erasmus University Medical Center, Rotterdam, The Netherlands.; Cybulski C; Department of Genetics and Pathology, International Hereditary Cancer Center, Pomeranian Medical University in Szczecin, Szczecin, Poland.; Wokolorczyk D; Department of Genetics and Pathology, International Hereditary Cancer Center, Pomeranian Medical University in Szczecin, Szczecin, Poland.; Ong KR; Department of Clinical Genetics, Birmingham Women's Hospital, Birmingham, UK.; Huber C; Department of Clinical Genetics, Birmingham Women's Hospital, Birmingham, UK.; Salinas M; Hereditary Cancer Program, Catalan Institute of Oncology, Bellvitge Biomedical Research Institute, Barcelona, Spain.; Feliubadaló L; Hereditary Cancer Program, Catalan Institute of Oncology, Bellvitge Biomedical Research Institute, Barcelona, Spain.; Oosterwijk JC; University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.; van Zelst-Stams WAG; Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands; Department of Clinical Genetics, Maastricht University Medical Center, Maastricht, The Netherlands.; Cook J; Sheffield Clinical Genetics Service, Sheffield Children's NHS Foundation Trust, Sheffield, UK.; Rosario DJ; Royal Hallamshire Hospital, Sheffield, UK.; Maxwell K; Basser Research Center, University of Pennsylvania, Philadelphia, PA, USA.; Powers J; Basser Research Center, University of Pennsylvania, Philadelphia, PA, USA.; Buys S; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.; Lyman J; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.; Ausems MGEM; Department of Genetics, Division Laboratories, Pharmacy and Biomedical Genetics, University Medical Centre Utrecht, Utrecht, The Netherlands.; Schmutzler RK; Center for Familial Breast and Ovarian Cancer and Center for Integrated Oncology (CIO), Faculty of Medicine, University Hospital Cologne, Cologne, Germany.; Rhiem K; Center for Familial Breast and Ovarian Cancer and Center for Integrated Oncology (CIO), Faculty of Medicine, University Hospital Cologne, Cologne, Germany.; Izatt L; Clinical Genetics Service, Guy's and St. Thomas' NHS Foundation Trust, London, UK.; Tripathi V; Clinical Genetics Service, Guy's and St. Thomas' NHS Foundation Trust, London, UK.; Teixeira MR; Department of Laboratory Genetics and IPO Porto Research Center, Portuguese Oncology Institute (IPO Porto), Porto, Portugal; School of Medicine and Biomedical Sciences (ICBAS), University of Porto, Porto, Portugal.; Cardoso M; Department of Laboratory Genetics and IPO Porto Research Center, Portuguese Oncology Institute (IPO Porto), Porto, Portugal.; Foulkes WD; Cancer Research Program, Research Institute of McGill University Health Centre, Montreal, Canada; Lady Davis Institute and Division of Medical Genetics, Jewish General Hospital, McGill University, Montreal, Canada.; Aprikian A; Cancer Research Program, Research Institute of McGill University Health Centre, Montreal, Canada; Departments of Surgery and Oncology, McGill University, Montreal, Canada.; Davidson R; West of Scotland Genetic Service, Queen Elizabeth University Hospital, Glasgow, UK.; Longmuir M; West of Scotland Genetic Service, Queen Elizabeth University Hospital, Glasgow, UK.; Ruijs MWG; Department of Clinical Genetics, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Blom EW; Department of Clinical Genetics, Maastricht University Medical Center, Maastricht, The Netherlands.; van Engelen K; Department of Human Genetics, Amsterdam University Medical Center, Amsterdam, The Netherlands.; Williams R; School of Clinical Medicine, UNSW Medicine & Health, University of New South Wales, Sydney, Australia; Hereditary Cancer Centre, Prince of Wales Hospital, Randwick, Australia.; Andrews L; Prince of Wales Clinical School, Faculty of Medicine, University of New South Wales, Sydney, Australia; Hereditary Cancer Centre, Prince of Wales Hospital, Randwick, Australia.; Murphy DG; The Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia; Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Australia.; Saya S; Department of General Practice and Primary Care, University of Melbourne, Melbourne, Australia.; Halliday D; Oxford Centre for Genomic Medicine, Oxford University Hospitals NHS Trust, Oxford, UK.; Walker L; Oxford Centre for Genomic Medicine, Oxford University Hospitals NHS Trust, Oxford, UK.; Liljegren A; Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden.; Carlsson S; Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden.; Azzabi A; Northern Genetics Service, Newcastle upon Tyne Hospitals, Newcastle upon Tyne, UK.; Jobson I; Northern Genetics Service, Newcastle upon Tyne Hospitals, Newcastle upon Tyne, UK.; Snape K; St. George's Hospital, London, UK.; Gowie M; St. George's Hospital, London, UK.; Harris M; Familial Cancer Centre, Monash Health, Clayton, Australia.; Tischkowitz M; East Anglian Medical Genetics Service, Cambridge University Hospitals NHS Trust, Cambridge, UK; Department of Genomic Medicine, NIHR Cambridge Biomedical Research Centre, University of Cambridge, Cambridge, UK.; Taylor A; East Anglian Medical Genetics Service, Cambridge University Hospitals NHS Trust, Cambridge, UK.; Kirk J; Familial Cancer Service, Crown Princess Mary Cancer Centre, Westmead Hospital, Sydney, Australia; Centre for Cancer Research, Westmead Institute for Medical Research, Sydney Medical School, University of Sydney, Sydney, Australia.; Susman R; Genetic Health Queensland, Royal Brisbane & Women's Hospital, Herston, Australia.; Chen-Shtoyerman R; The Adelson School of Medicine and Department of Molecular Biology, Ariel University, Ariel, Israel; The Genetic Institute, Kaplan Medical Center, Rehovot, Israel.; Spigelman A; Hunter Family Cancer Service, Waratah, Australia; St. Vincent's Clinical School, University of New South Wales, Sydney, Australia; Cancer Genetics Clinic, The Kinghorn Cancer Centre, St. Vincent's Hospital, Sydney, Australia.; Pachter N; Genetic Services of Western Australia, King Edward Memorial Hospital, Subiaco, Australia; Faculty of Health and Medical Sciences, University of Western Australia, Perth, Australia.; Ahmed M; North East Thames Regional Genetics Service, Great Ormond Street Hospital NHS Foundation Trust, London, UK.; Cajal TRY; Hospital de Sant Pau, Barcelona, Spain.; Krajc M; Institute of Oncology, Ljubljana, Slovenia.; Cleaver R; Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK.; Cruellas M; Hereditary Cancer Genetics Group, Medical Oncology Department, Hospital Vall d'Hebron, Vall d'Hebron Institute of Oncology, Barcelona, Spain; Medical Oncology Department, Hospital Clínico Univesitario Lozano Blesa, Zaragoza, Spain.; Perez-Ballestero E; Hereditary Cancer Genetics Group, Medical Oncology Department, Hospital Vall d'Hebron, Vall d'Hebron Institute of Oncology, Barcelona, Spain.; Brady AF; North West Thames Regional Genetics Service, Northwick Park Hospital, London North West University Healthcare NHS Trust, Harrow, UK.; Gallagher D; St. James's Hospital, Dublin, Ireland.; Donaldson A; St. Michael's Hospital, Bristol, UK.; Barwell J; University of Leicester, Leicester, UK; University Hospitals Leicester, Leicester, UK.; Nicolai N; Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.; Friedman E; Chaim Sheba Medical Center, Tel-Hashomer, Israel.; Hall MJ; Fox Chase Cancer Center, Philadelphia, PA, USA.; Greenhalgh L; Clinical Genetics Service, Liverpool Women's Hospital, Liverpool, UK.; Murthy V; Radiation Oncology, Advanced Centre for Treatment Research and Education in Cancer (ACTREC), Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India.; Copakova L; National Cancer Institute, Bratislava, Slovakia.; McGrath JS; North Bristol NHS Trust, Bristol, UK; University of Exeter Medical School, Exeter, UK.; Cooke P; New Cross Hospital, Wolverhampton, UK.; Arun B; MD Anderson Cancer Center, University of Texas, Houston, TX, USA.; Myhill K; Cancer Genetics Unit and Academic Urology Unit, The Royal Marsden NHS Foundation Trust, London, UK.; Hogben M; Cancer Genetics Unit and Academic Urology Unit, The Royal Marsden NHS Foundation Trust, London, UK.; Hussain S; Oncogenetics Team, Genetics and Epidemiology, The Institute of Cancer Research, London, UK.; Aaronson NK; Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Ardern-Jones A; Cancer Genetics Unit and Academic Urology Unit, The Royal Marsden NHS Foundation Trust, London, UK.; Bangma CH; Department of Urology, Erasmus University Medical Center, Rotterdam, The Netherlands.; Castro E; Hospital Universitario 12 de Octubre, Madrid, Spain.; Dearnaley D; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK.; Eccles DM; Wessex Clinical Genetics Service, Princess Anne Hospital, Southampton, UK; Cancer Sciences, The University of Southampton, Southampton, UK.; Tricker K; Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK.; Falconer A; Imperial College Healthcare NHS Trust, London, UK.; Gronberg H; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.; Hamdy FC; Churchill Hospital, Oxford, UK; Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK.; Khoo V; Cancer Genetics Unit and Academic Urology Unit, The Royal Marsden NHS Foundation Trust, London, UK; St. George's Hospital, London, UK; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK; Department of Medicine, The University of Melbourne, Parkville, Australia.; Lilja H; Department of Translational Medicine, Lund University, Malmö, Sweden; Departments of Pathology and Laboratory Medicine, Surgery and Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.; Lindeman GJ; Parkville Familial Cancer Centre, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Australia; Department of Medicine, The University of Melbourne, Parkville, Australia; Cancer Biology and Stem Cells Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, Australia.; Lubinski J; Department of Genetics and Pathology, International Hereditary Cancer Center, Pomeranian Medical University in Szczecin, Szczecin, Poland.; Axcrona K; Department of Urology, Akershus University Hospital, Lørenskog, Norway.; Mikropoulos C; Royal Surrey Hospital, Guildford, UK.; Mitra A; University College London Hospitals NHS Foundation Trust, London, UK.; Offman J; Centre for Cancer Screening, Prevention and Early Diagnosis, Wolfson Institute of Population Health, Queen Mary University, London, UK.; Rennert G; Technion-Israel Institute of Technology, Haifa, Israel.; Suri M; Nottingham City Hospital, Nottingham, UK.; Dudderidge T; University Hospital Southampton, Southampton, UK.; Brook MN; Oncogenetics Team, Genetics and Epidemiology, The Institute of Cancer Research, London, UK.; Kote-Jarai Z; Oncogenetics Team, Genetics and Epidemiology, The Institute of Cancer Research, London, UK.; Eeles RA; Oncogenetics Team, Genetics and Epidemiology, The Institute of Cancer Research, London, UK; Cancer Genetics Unit and Academic Urology Unit, The Royal Marsden NHS Foundation Trust, London, UK. Electronic address: ros.eeles@icr.ac.uk.
Publisher: Elsevier Science Country of Publication: Switzerland NLM ID: 7512719 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-7560 (Electronic) Linking ISSN: 03022838 NLM ISO Abbreviation: Eur Urol Subsets: MEDLINE
Academic Journal
Page, EC; Bancroft, EK; Brook, MN; Assel, M; Hassan Al Battat, M; Thomas, S; Taylor, N; Chamberlain, A; Pope, J; Raghallaigh, HN; Evans, DG; Rothwell, J; Maehle, L; Grindedal, EM; James, P; Mascarenhas, L; McKinley, J; Side, L; Thomas, T; van Asperen, C; Vasen, H; Kiemeney, LA; Ringelberg, J; Jensen, TD; Osther, PJS; Helfand, BT; Genova, E; Oldenburg, RA; Cybulski, C; Wokolorczyk, D; Ong, K-R; Huber, C; Lam, J; Taylor, L; Salinas, M; Feliubadaló, L; Oosterwijk, JC; van Zelst-Stams, W; Cook, J; Rosario, DJ; Domchek, S; Powers, J; Buys, S; O'Toole, K; Ausems, MGEM; Schmutzler, RK; Rhiem, K; Izatt, L; Tripathi, V; Teixeira, MR; Cardoso, M; Foulkes, WD; Aprikian, A; van Randeraad, H; Davidson, R; Longmuir, M; Ruijs, MWG; Helderman van den Enden, ATJM; Adank, M; Williams, R; Andrews, L; Murphy, DG; Halliday, D; Walker, L; Liljegren, A; Carlsson, S; Azzabi, A; Jobson, I; Morton, C; Shackleton, K; Snape, K; Hanson, H; Harris, M; Tischkowitz, M; Taylor, A; Kirk, J; Susman, R; Chen-Shtoyerman, R; Spigelman, A; Pachter, N; Ahmed, M; Ramon Y Cajal, T; Zgajnar, J; Brewer, C; Gadea, N; Brady, AF; van Os, T; Gallagher, D; Johannsson, O; Donaldson, A; Barwell, J; Nicolai, N; Friedman, E; Obeid, E; Greenhalgh, L; Murthy, V; Copakova, L; Saya, S; McGrath, J; Cooke, P; Rønlund, K; Richardson, K; Henderson, A; Teo, SH; Arun, B; Kast, K; Dias, A; Aaronson, NK; Ardern-Jones, A; Bangma, CH; Castro, E; Dearnaley, D; Eccles, DM; Tricker, K; Eyfjord, J; Falconer, A; Foster, C; Gronberg, H; Hamdy, FC; Stefansdottir, V; Khoo, V; Lindeman, GJ; Lubinski, J; Axcrona, K; Mikropoulos, C; Mitra, A; Moynihan, C; Rennert, G; Suri, M; Wilson, P; Dudderidge, T; IMPACT Study Collaborators; Offman, J; Kote-Jarai, Z; Vickers, A; Lilja, H; Eeles, RA
Eur Urol
EUROPEAN UROLOGY
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Institut dInvestigació Biomèdica Sant Pau (IIB Sant Pau)
Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))
Dipòsit Digital de la UB
Universidad de Barcelona
The IMPACT Study Collaborators 2019, 'Interim Results from the IMPACT Study: Evidence for Prostate-specific Antigen Screening in BRCA2 Mutation Carriers', European Urology, vol. 76, no. 6, pp. 831-842. https://doi.org/10.1016/j.eururo.2019.08.019
European Urology, 76, 6, pp. 831-842
Page, E C, Bancroft, E K, Brook, M N, Assel, M, Hassan Al Battat, M, Thomas, S, Taylor, N, Chamberlain, A, Pope, J, Raghallaigh, H N, Evans, D G, Rothwell, J, Maehle, L, Grindedal, E M, James, P, Mascarenhas, L, McKinley, J, Side, L, Thomas, T, van Asperen, C, Vasen, H, Kiemeney, L A, Ringelberg, J, Jensen, T D, Osther, P J S, Helfand, B T, Genova, E, Oldenburg, R A, Cybulski, C, Wokolorczyk, D, Ong, K-R, Huber, C, Lam, J, Taylor, L, Salinas, M, Feliubadaló, L, Oosterwijk, J C, van Zelst-Stams, W, Cook, J, Rosario, D J, Domchek, S, Powers, J, Buys, S, O'Toole, K, Ausems, M G E M, Schmutzler, R K, Rhiem, K, Izatt, L, Johannsson, O, Rønlund, K & IMPACT Collaborators 2019, ' Interim Results from the IMPACT Study : Evidence for Prostate-specific Antigen Screening in BRCA2 Mutation Carriers ', European Urology, vol. 76, no. 6, pp. 831-842 . https://doi.org/10.1016/j.eururo.2019.08.019
IMPACT study collaborators 2019, 'Interim Results from the IMPACT Study: Evidence for Prostate-specific Antigen Screening in BRCA2 Mutation Carriers', European Urology. https://doi.org/10.1016/j.eururo.2019.08.019
EUROPEAN UROLOGY
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Institut dInvestigació Biomèdica Sant Pau (IIB Sant Pau)
Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))
Dipòsit Digital de la UB
Universidad de Barcelona
The IMPACT Study Collaborators 2019, 'Interim Results from the IMPACT Study: Evidence for Prostate-specific Antigen Screening in BRCA2 Mutation Carriers', European Urology, vol. 76, no. 6, pp. 831-842. https://doi.org/10.1016/j.eururo.2019.08.019
European Urology, 76, 6, pp. 831-842
Page, E C, Bancroft, E K, Brook, M N, Assel, M, Hassan Al Battat, M, Thomas, S, Taylor, N, Chamberlain, A, Pope, J, Raghallaigh, H N, Evans, D G, Rothwell, J, Maehle, L, Grindedal, E M, James, P, Mascarenhas, L, McKinley, J, Side, L, Thomas, T, van Asperen, C, Vasen, H, Kiemeney, L A, Ringelberg, J, Jensen, T D, Osther, P J S, Helfand, B T, Genova, E, Oldenburg, R A, Cybulski, C, Wokolorczyk, D, Ong, K-R, Huber, C, Lam, J, Taylor, L, Salinas, M, Feliubadaló, L, Oosterwijk, J C, van Zelst-Stams, W, Cook, J, Rosario, D J, Domchek, S, Powers, J, Buys, S, O'Toole, K, Ausems, M G E M, Schmutzler, R K, Rhiem, K, Izatt, L, Johannsson, O, Rønlund, K & IMPACT Collaborators 2019, ' Interim Results from the IMPACT Study : Evidence for Prostate-specific Antigen Screening in BRCA2 Mutation Carriers ', European Urology, vol. 76, no. 6, pp. 831-842 . https://doi.org/10.1016/j.eururo.2019.08.019
IMPACT study collaborators 2019, 'Interim Results from the IMPACT Study: Evidence for Prostate-specific Antigen Screening in BRCA2 Mutation Carriers', European Urology. https://doi.org/10.1016/j.eururo.2019.08.019
Academic Journal
Prinsen AMA; Department of Urology, Sint Antonius Ziekenhuis, Nieuwegein, The Netherlands.; Wagensveld IM; Department of Radiology, Erasmus University Medical Centre, Rotterdam, The Netherlands.; Osses DF; Department of Urology, Radboudumc, Nijmegen, The Netherlands.; Groenendijk PM; Bergman Clinics, Rijswijk, The Netherlands.; Zijta FM; Department of Radiology and Nuclear Medicine, Maastricht University Medical Center, Maastricht, The Netherlands.; Busstra MB; Department of Urology, Erasmus MC Cancer Institute, Erasmus University Medical Centre, Rotterdam, The Netherlands.; Rociu E; Department of Radiology, Franciscus Ziekenhuis, Rotterdam, The Netherlands.; Barentsz JO; Andros Clinics, Arnhem, The Netherlands.; Sedelaar JPM; Department of Urology, Radboudumc, Nijmegen, The Netherlands.; Arbeel B; Department of Urology, Flevoziekenhuis, Almere, The Netherlands.; Roeleveld T; Department of Urology, Northwest Clinics, Alkmaar, The Netherlands.; Geenen R; Department of Radiology, Northwest Clinics, Alkmaar, The Netherlands.; Koeter I; Department of Urology, Beatrix Ziekenhuis, Gorinchem, The Netherlands.; van der Meer S; Department of Urology, Jeroen Bosch Ziekenhuis, 's-Hertogenbosch, The Netherlands.; Cappendijk VC; Department of Radiology, Jeroen Bosch Ziekenhuis, 's-Hertogenbosch, The Netherlands.; Klaver S; Department of Urology, Maasstad Ziekenhuis, Rotterdam, The Netherlands.; van der Lely H; Department of Radiology, Maasstad Ziekenhuis, Rotterdam, The Netherlands.; Wolters T; Department of Urology, Deventer Ziekenhuis, Deventer, The Netherlands.; Leter MR; Department of Urology, Dijklander Ziekenhuis, Hoorn, The Netherlands.; van der Poel HG; Department of Urology, Netherlands Cancer Institute, Amsterdam, The Netherlands; Department of Urology, Amsterdam University Medical Centers, Amsterdam, The Netherlands.; Heijmink SWTPJ; Department of Radiology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Immerzeel J; Andros Clinics, Arnhem, The Netherlands.; Leijte JAP; Department of Urology, Amphia Ziekenhuis, Breda, The Netherlands.; van Roermund JGH; Department of Urology, Maastricht University Medical Center, Maastricht, The Netherlands.; Miclea RL; Department of Radiology and Nuclear Medicine, Maastricht University Medical Center, Maastricht, The Netherlands.; Planken E; Department of Urology, Admiraal de Ruyter Ziekenhuis, Goes, The Netherlands.; Vis AN; Department of Urology, Amsterdam University Medical Centers, Amsterdam, The Netherlands.; de Jong IJ; Department of Urology, Groningen University Medical Center, Groningen, The Netherlands.; Tijsterman J; Department of Urology, Haga Ziekenhuis, The Hague, The Netherlands.; Wolterbeek D; Department of Radiology, Haga Ziekenhuis, The Hague, The Netherlands.; Claessen A; Department of Urology, Rode Kruis Ziekenhuis, Beverwijk, The Netherlands.; Nederend J; Department of Radiology, Catharina Ziekenhuis, Eindhoven, The Netherlands.; Bangma CH; Department of Urology, Erasmus MC Cancer Institute, Erasmus University Medical Centre, Rotterdam, The Netherlands.; Roobol MJ; Department of Urology, Erasmus MC Cancer Institute, Erasmus University Medical Centre, Rotterdam, The Netherlands.; Remmers S; Department of Urology, Erasmus MC Cancer Institute, Erasmus University Medical Centre, Rotterdam, The Netherlands.; van den Bergh RCN; Department of Urology, Erasmus MC Cancer Institute, Erasmus University Medical Centre, Rotterdam, The Netherlands.; Somford DM; Department of Urology, Canisius Wilhelmina Ziekenhuis, Nijmegen, The Netherlands.; Schoots IG; Department of Radiology, Erasmus University Medical Centre, Rotterdam, The Netherlands. Electronic address: i.schoots@erasmusmc.nl.
Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101724904 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2588-9311 (Electronic) Linking ISSN: 25889311 NLM ISO Abbreviation: Eur Urol Oncol Subsets: MEDLINE
Academic Journal
Roobol MJ; Department of Urology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, the Netherlands.; de Vos II; Department of Urology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, the Netherlands.; Månsson M; Department of Urology, Sahlgrenska Academy at Goteborg University, Gothenburg, Sweden.; Godtman RA; Department of Urology, Sahlgrenska Academy at Goteborg University, Gothenburg, Sweden.; Talala KM; Cancer Society of Finland, Helsinki.; den Hond E; Provincial Institute for Hygiene, Antwerp, Belgium.; Nelen V; Provincial Institute for Hygiene, Antwerp, Belgium.; Villers A; Department of Urology, Lille, Universite Lille Nord de France, Lille, France.; Poinas G; Department of Urology, Clinique Beau Soleil, Montpellier, France.; Kwiatkowski M; Department of Urology, Cantonal Hospital Aarau, Aarau, Switzerland.; Member of Medical Faculty, University of Basel, Basel, Switzerland.; Department of Urology, Academic Hospital Braunschweig, Braunschweig, Germany.; Wyler S; Department of Urology, Cantonal Hospital Aarau, Aarau, Switzerland.; Member of Medical Faculty, University of Basel, Basel, Switzerland.; Recker F; Department of Urology, Cantonal Hospital Aarau, Aarau, Switzerland.; Puliti D; Oncologic Network, Prevention and Research Institute (ISPRO), Florence, Italy.; Gorini G; Oncologic Network, Prevention and Research Institute (ISPRO), Florence, Italy.; Zappa M; Oncologic Network, Prevention and Research Institute (ISPRO), Florence, Italy.; Paez A; Department of Urology, Hospital Universitario de Fuenlabrada, Madrid.; Lujan M; Department of Urology, Hospital Universitario Infanta Cristina, Madrid.; Bangma CH; Department of Urology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, the Netherlands.; Tammela T; Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.; Department of Urology, Tampere University Hospital, Tampere, Finland.; Schröder FH; Department of Urology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, the Netherlands.; Remmers S; Department of Urology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, the Netherlands.; Hugosson J; Department of Urology, Sahlgrenska Academy at Goteborg University, Gothenburg, Sweden.; Auvinen A; Prostate Cancer Research Center, Faculty of Social Sciences, Tampere University, Tampere, Finland.
Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print Cited Medium: Internet ISSN: 1533-4406 (Electronic) Linking ISSN: 00284793 NLM ISO Abbreviation: N Engl J Med Subsets: MEDLINE
Academic Journal
Kroon LJ; Department of Pathology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, the Netherlands.; Department of Urology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, the Netherlands.; Anser Prostate Clinic, Rotterdam, the Netherlands.; Remmers S; Department of Urology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, the Netherlands.; Busstra MB; Anser Prostate Clinic, Rotterdam, the Netherlands.; Gan M; Anser Prostate Clinic, Rotterdam, the Netherlands.; Klaver S; Anser Prostate Clinic, Rotterdam, the Netherlands.; Rietbergen JBW; Anser Prostate Clinic, Rotterdam, the Netherlands.; van der Slot MA; Department of Pathology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, the Netherlands.; Department of Urology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, the Netherlands.; Anser Prostate Clinic, Rotterdam, the Netherlands.; Hollemans E; Department of Pathology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, the Netherlands.; Kweldam CF; Department of Pathology, Maasstad Hospital, Rotterdam, the Netherlands.; Bangma CH; Department of Urology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, the Netherlands.; Roobol MJ; Department of Urology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, the Netherlands.; van Leenders GJLH; Department of Pathology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, the Netherlands.
Publisher: Blackwell Scientific Publications Country of Publication: England NLM ID: 7704136 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2559 (Electronic) Linking ISSN: 03090167 NLM ISO Abbreviation: Histopathology Subsets: MEDLINE
Academic Journal
de Vos II; Department of Urology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.; Marenghi C; Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.; Badenchini F; Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.; Boevé ER; Department of Urology, Sint Franciscus Hospital, Rotterdam, The Netherlands.; Lozano-Uruñuela F; Department of Urology, Hospital Universitario de Navarra, Pamplona, Spain.; Graefen M; Department of Urology, Martini Klinik, Hamburg, Germany.; Rannikko AS; Helsinki University Hospital, Helsinki, Finland.; Department of Urology and Research Program in Systems Oncology, University of Helsinki, Helsinki, Finland.; Staerman F; Department of Urology, Polyclinique Reims-Bezannes, Bezannes, France.; Sugimoto M; Department of Urology, Faculty of Medicine, Kagawa University, Kagawa, Japan.; Kato T; Department of Urology, Faculty of Medicine, Kagawa University, Kagawa, Japan.; Somford DM; Department of Urology, Canisius Wilhelmina Hospital, Nijmegen, The Netherlands.; Frydenberg M; Department of Surgery, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Australia.; Department of Urology, Cabrini Institute, Cabrini Health, Melbourne, Australia.; Bangma CH; Department of Urology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.; Remmers S; Department of Urology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.; Roobol MJ; Department of Urology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.
Publisher: Blackwell Science Country of Publication: England NLM ID: 100886721 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1464-410X (Electronic) Linking ISSN: 14644096 NLM ISO Abbreviation: BJU Int Subsets: MEDLINE
Academic Journal
Kroon LJ; Department of Pathology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands. l.kroon@erasmusmc.nl.; Department of Urology, Erasmus MC Cancer Institute, University Medical Center, Na-15, P.O. Box 2040, 3000 CA, Rotterdam, The Netherlands. l.kroon@erasmusmc.nl.; Anser Prostate Network, Rotterdam, The Netherlands. l.kroon@erasmusmc.nl.; Leeuwenburgh KP; Department of Urology, Erasmus MC Cancer Institute, University Medical Center, Na-15, P.O. Box 2040, 3000 CA, Rotterdam, The Netherlands.; Anser Prostate Network, Rotterdam, The Netherlands.; Remmers S; Department of Urology, Erasmus MC Cancer Institute, University Medical Center, Na-15, P.O. Box 2040, 3000 CA, Rotterdam, The Netherlands.; Kweldam CF; Anser Prostate Network, Rotterdam, The Netherlands.; van den Bergh RCN; Anser Prostate Network, Rotterdam, The Netherlands.; Bangma CH; Department of Urology, Erasmus MC Cancer Institute, University Medical Center, Na-15, P.O. Box 2040, 3000 CA, Rotterdam, The Netherlands.; Anser Prostate Network, Rotterdam, The Netherlands.; van Leenders GJLH; Department of Pathology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.
Publisher: Springer International Country of Publication: Germany NLM ID: 9423843 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-2307 (Electronic) Linking ISSN: 09456317 NLM ISO Abbreviation: Virchows Arch Subsets: MEDLINE
Academic Journal
Kroon LJ; Department of Pathology, Erasmus MC Cancer Institute, University Medical Centre, Rotterdam, The Netherlands. l.kroon@erasmusmc.nl.; Department of Urology, Erasmus MC Cancer Institute, University Medical Centre, Rotterdam, The Netherlands. l.kroon@erasmusmc.nl.; Remmers S; Department of Urology, Erasmus MC Cancer Institute, University Medical Centre, Rotterdam, The Netherlands.; Hollemans E; Department of Pathology, Erasmus MC Cancer Institute, University Medical Centre, Rotterdam, The Netherlands.; Bangma CH; Department of Urology, Erasmus MC Cancer Institute, University Medical Centre, Rotterdam, The Netherlands.; Roobol MJ; Department of Urology, Erasmus MC Cancer Institute, University Medical Centre, Rotterdam, The Netherlands.; van Leenders GJLH; Department of Pathology, Erasmus MC Cancer Institute, University Medical Centre, Rotterdam, The Netherlands.
Publisher: Nature Publishing Group Country of Publication: England NLM ID: 9815755 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5608 (Electronic) Linking ISSN: 13657852 NLM ISO Abbreviation: Prostate Cancer Prostatic Dis Subsets: MEDLINE; In Process
Academic Journal
Heijnsdijk, EAM; Bangma, CH; Borras, JM; de, Carvalho TM; Castells, X; Eklund, M; Espinas, JA; Graefen, M; Gronberg, H; Lansdorp-Vogelaar, I
INTERNATIONAL JOURNAL OF CANCER. 142(4):741-746
Academic Journal
Beckmann KR; Cancer Epidemiology and Population Health Research, University of South Australia, Adelaide, South Australia, Australia.; Translational Oncology and Urology Research, Kings College London, London, UK.; Bangma CH; Department of Urology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Helleman J; Department of Urology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Bjartell A; Department of Translational Medicine, Skane University Hospital, Malmo, Sweden.; Carroll PR; Department of Urology, University of California San Francisco, San Francisco, California, USA.; Morgan T; Michigan Urological Surgery Improvement Collaborative, University of Michigan, Ann Arbor, Michigan, USA.; Nieboer D; Department of Urology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Santaolalla A; Translational Oncology and Urology Research, Kings College London, London, UK.; Trock BJ; The James Buchanan Brady Urological Institute, John Hopkins University, Baltimore, Maryland, USA.; Valdagni R; Radiation Oncology and Prostate Cancer Program, Istituto Nazionale Dei Tumori, Milano, Italy.; Roobol MJ; Department of Urology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
Publisher: Wiley-Liss Country of Publication: United States NLM ID: 8101368 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0045 (Electronic) Linking ISSN: 02704137 NLM ISO Abbreviation: Prostate Subsets: MEDLINE
Academic Journal
Bruinsma, SM; Roobol, MJ; Carroll, PR; Klotz, L; Pickles, T; Moore, CM; Gnanapragasam, VJ; Villers, A; Rannikko, A; Valdagni, R; Frydenberg, M; Kakehi, Y; Filson, CP; Bangma, CH; Movember Foundation's Global Action Plan Prostate Cancer, Active
Bruinsma, S M, Roobol, M J, Carroll, P R, Klotz, L, Pickles, T, Moore, C M, Gnanapragasam, V J, Villers, A, Rannikko, A, Valdagni, R, Frydenberg, M, Kakehi, Y, Filson, C P, Bangma , C H, Movember Foundation's Global Action Plan Prostate Cancer Active Surveillance (GAP3) consortium & Muir, K 2017, 'Expert consensus document : Semantics in active surveillance for men with localized prostate cancer-results of a modified Delphi consensus procedure', Nature Reviews. Urology, vol. 14, no. 5, pp. 312-322. https://doi.org/10.1038/nrurol.2017.26
Academic Journal
Oprea-Lager DE; Department of Radiology & Nuclear Medicine, Amsterdam University Medical Center, VU University, Amsterdam, The Netherlands.; Department of Medical Imaging, Radboud University Medical Centre, Nijmegen, The Netherlands.; van Elst T; Department of Urology, Canisius Wilhelmina Hospital, Nijmegen, The Netherlands.; Department of Medical Oncology, Radboud University Medical Centre, Nijmegen, The Netherlands.; Aluwini S; Department of Radiation Oncology, University Medical Center Groningen, Groningen, The Netherlands.; Dewulf E; Centre for Decision Analysis & Support, Ismar Healthcare NV, Lier, Belgium.; der Poel HV; Department of Urology, Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, The Netherlands.; Department of Urology, Amsterdam University Medical Center, VU University, Amsterdam, The Netherlands.; Stoevelaar H; Centre for Decision Analysis & Support, Ismar Healthcare NV, Lier, Belgium.; Bangma CH; Department of Urology, Erasmus MC, Rotterdam, The Netherlands.; Beeker A; Department of Internal Medicine, Spaarne Gasthuis, Hoofddorp, The Netherlands.; Boudewijns S; Department of Medical Oncology, Bravis Hospital Roosendaal, Roosendaal, The Netherlands.; Budiharto T; Department of Radiotherapy, Catharina Hospital, Eindhoven, The Netherlands.; de Jong IJ; Department of Urology, University Medical Center Groningen, Groningen, The Netherlands.; de Vries KC; Department of Radiotherapy, Erasmus MC, Rotterdam, The Netherlands.; Donswijk ML; Department of Nuclear Medicine, Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, The Netherlands.; Fütterer JJ; Department of Medical Imaging, Radboud University Medical Centre, Nijmegen, The Netherlands.; Hamberg P; Department of Medical Oncology, Franciscus Gasthuis & Vlietland, Rotterdam & Schiedam, The Netherlands.; Heijmen L; Department of Radiology, Leiden University Medical Center, Leiden, The Netherlands.; Hoekstra RJ; Department of Urology, Catharina Hospital, Eindhoven, The Netherlands.; Kerkhofs TMA; Department of Internal Medicine, Division of Medical Oncology, GROW School for Oncology and Developmental Biology, Maastricht University Medical Center+, Maastricht, The Netherlands.; Lavalaye J; Department of Nuclear Medicine, Sint Antonius Hospital, Utrecht & Nieuwegein, The Netherlands.; Bruin DL; Department of Urology, Martini Hospital, Groningen, The Netherlands.; Noordzij W; Department of Nuclear Medicine & Molecular Imaging, Medical Imaging Center Groningen, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.; Oving IM; Department of Internal Medicine, Ziekenhuis Groep Twente, Almelo, The Netherlands.; Robbrecht DGJ; Department of Medical Oncology, Erasmus MC, Rotterdam, The Netherlands.; Schaake EE; Department of Radiotherapy, Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, The Netherlands.; van de Luijtgaarden ACM; Department of Medical Oncology, Reinier Haga Prostate Cancer Centre, Delft, The Netherlands.; van den Bergh RCN; Department of Urology, Erasmus MC, Rotterdam, The Netherlands.; van den Berkmortel F; Department of Internal Medicine-Medical Oncology, Zuyderland MC, Sittard, The Netherlands.; van der Hulle T; Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands.; van der Mijn JCK; Department of Medical Oncology, Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, The Netherlands.; van Dodewaard-de Jong JM; Department of Internal Medicine, Meander Medical Center, Amersfoort, The Netherlands.; van Kruchten M; Department of Medical Oncology, University Medical Center Groningen, Groningen, The Netherlands.; van Leeuwen PJ; Department of Urology, Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, The Netherlands.; van Limbergen E; Department of Radiation Oncology (Maastro), GROW School for Oncology and Reproduction, Maastricht University Medical Centre+, Maastricht, The Netherlands.; van Moorselaar RJA; Department of Urology, Amsterdam University Medical Center, VU University, Amsterdam, The Netherlands.; van Oort IM; Department of Urology, Radboud University Medical Centre, Nijmegen, The Netherlands.; van Roermund JGH; Department of Urology, Maastricht University Medical Center+, Maastricht, The Netherlands.; van Soest RJ; Department of Urology, Franciscus Gasthuis & Vlietland, Rotterdam & Schiedam, The Netherlands.; Veninga T; Department of Radiotherapy, Institute Verbeeten, Tilburg, The Netherlands.; Vis AN; Department of Urology, Amsterdam University Medical Center, VU University, Amsterdam, The Netherlands.; Voortman J; Department of Medical Oncology, Amsterdam University Medical Center, VU University, Amsterdam, The Netherlands.; Willemse PM; Department of Urology, Cancer Center, University Medical Center Utrecht, Utrecht, The Netherlands.; Yakar D; Department of Radiology, Medical Imaging Center Groningen, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.; Department of Radiology, Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, The Netherlands.; Mehra N; Department of Medical Oncology, Radboud University Medical Centre, Nijmegen, The Netherlands.
Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101771568 Publication Model: eCollection Cited Medium: Internet ISSN: 2666-1683 (Electronic) Linking ISSN: 26661683 NLM ISO Abbreviation: Eur Urol Open Sci Subsets: PubMed not MEDLINE
Academic Journal
Tohi Y; Department of Urology, Faculty of Medicine, Kagawa University, Kagawa, Japan. Electronic address: yoto716yotoyoto@gmail.com.; Sahrmann JM; Jonsson Comprehensive Cancer Center, University of California-Los Angeles, Los Angeles, CA, USA; Institute for Precision Health, University of California-Los Angeles, Los Angeles, CA, USA; Department of Human Genetics, University of California-Los Angeles, Los Angeles, CA, USA; Department of Urology, David Geffen School of Medicine, University of California-Los Angeles, Los Angeles, CA, USA.; Arbet J; Jonsson Comprehensive Cancer Center, University of California-Los Angeles, Los Angeles, CA, USA; Institute for Precision Health, University of California-Los Angeles, Los Angeles, CA, USA; Department of Human Genetics, University of California-Los Angeles, Los Angeles, CA, USA; Department of Urology, David Geffen School of Medicine, University of California-Los Angeles, Los Angeles, CA, USA.; Kato T; Department of Urology, Faculty of Medicine, Kagawa University, Kagawa, Japan.; Lee LS; Department of Urology, Sengkang General Hospital and Singapore General Hospital, Singapore.; Peacock M; BC Cancer, University of British Columbia, Vancouver, Canada.; Ginsburg K; Department of Urology, Wayne State University, Detroit, MI, USA.; Pavlovich C; Department of Urology, James Buchanan Brady Urological Institute, Johns Hopkins University, Baltimore, MD, USA.; Carroll P; Department of Urology, University California-San Francisco, San Francisco, CA, USA.; Bangma CH; Department of Urology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Sugimoto M; Department of Urology, Faculty of Medicine, Kagawa University, Kagawa, Japan.; Boutros PC; Jonsson Comprehensive Cancer Center, University of California-Los Angeles, Los Angeles, CA, USA; Institute for Precision Health, University of California-Los Angeles, Los Angeles, CA, USA; Department of Human Genetics, University of California-Los Angeles, Los Angeles, CA, USA; Department of Urology, David Geffen School of Medicine, University of California-Los Angeles, Los Angeles, CA, USA.
Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101724904 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2588-9311 (Electronic) Linking ISSN: 25889311 NLM ISO Abbreviation: Eur Urol Oncol Subsets: MEDLINE
Academic Journal
Bus MTJ; Department of Urology, University Medical Center Groningen, Groningen, The Netherlands. Electronic address: m.t.j.bus@umcg.nl.; Verheijen ECJ; Department of Gynaecology, PoliDirect, Goor, The Netherlands.; Vaittinen T; WHO Collaboration Center on Health in All Policies and Social Determinants of Health, Tampere University, Tampere, Finland.; Holzhauer C; Department of Urology, University Medical Center Groningen, Groningen, The Netherlands.; Bangma CH; Department of Urology, Erasmus Medical Center, Rotterdam, The Netherlands.; Leliveld-Kors A; Department of Urology, University Medical Center Groningen, Groningen, The Netherlands.
Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101665661 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2405-4569 (Electronic) Linking ISSN: 24054569 NLM ISO Abbreviation: Eur Urol Focus Subsets: MEDLINE
Review
Barbieri, CE; Bangma, CH; Bjartell, A; Catto, JWF; Culig, Z; Gronberg, H; Luo, J; Visakorpi, T; Rubin, MA
EUROPEAN UROLOGY. 64(4):567-576
Academic Journal
Bokhorst LP; Lepistö I; Kakehi Y; Bangma CH; Pickles T; Valdagni R; Alberts AR; Semjonow A; Strölin P; Montesino MF; Berge V; Roobol MJ; Rannikko A
BJU International. 118:366-371
Academic Journal
van der Starre CM; Netherlands Comprehensive Cancer Organisation, Utrecht, the Netherlands.; Department of Urology, University Medical Center Groningen, Groningen, the Netherlands.; Bangma CH; Department of Urology, Erasmus University Medical Centre, Rotterdam, the Netherlands.; Bijlsma MJ; Netherlands Comprehensive Cancer Organisation, Utrecht, the Netherlands.; PharmacoTherapy, -Epidemiology and -Economics, Groningen Research Institute of Pharmacy, University of Groningen, Groningen, the Netherlands.; van den Bergh ACM; Radiation Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Kiemeney LALM; Department IQ Health, Radboud university medical center, Nijmegen, the Netherlands.; Kievit W; Department IQ Health, Radboud university medical center, Nijmegen, the Netherlands.; Vos K; Patient Representative, Dutch Prostate Cancer Foundation (Prostaatkankerstichting), Utrecht, The Netherlands.; Somford DM; Department of Urology, Canisius-Wilhelmina Hospital, Nijmegen, the Netherlands.; Prosper Prostate Cancer Clinics, Nijmegen/Eindhoven, The Netherlands.; Wildeman SM; Department of Urology, Franciscus Gasthuis en Vlietland, Rotterdam, the Netherlands.; Aben KKH; Netherlands Comprehensive Cancer Organisation, Utrecht, the Netherlands. k.aben@iknl.nl.; Department IQ Health, Radboud university medical center, Nijmegen, the Netherlands. k.aben@iknl.nl.; de Jong IJ; Department of Urology, University Medical Center Groningen, Groningen, the Netherlands.; Pos FJ; Radiation Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Heesterman BL; Netherlands Comprehensive Cancer Organisation, Utrecht, the Netherlands.
Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE
Academic Journal
European Urology. 62:195-200
검색 결과 제한하기
제한된 항목
[검색어] Bangma CH
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어